806 related articles for article (PubMed ID: 32023927)
1. Protofibrils of Amyloid-β are Important Targets of a Disease-Modifying Approach for Alzheimer's Disease.
Ono K; Tsuji M
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32023927
[TBL] [Abstract][Full Text] [Related]
2. High molecular weight amyloid β
Yasumoto T; Takamura Y; Tsuji M; Watanabe-Nakayama T; Imamura K; Inoue H; Nakamura S; Inoue T; Kimura A; Yano S; Nishijo H; Kiuchi Y; Teplow DB; Ono K
FASEB J; 2019 Aug; 33(8):9220-9234. PubMed ID: 31084283
[TBL] [Abstract][Full Text] [Related]
3. Alzheimer's disease as oligomeropathy.
Ono K
Neurochem Int; 2018 Oct; 119():57-70. PubMed ID: 28821400
[TBL] [Abstract][Full Text] [Related]
4. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
5. Alzheimer's disease-associated neurotoxic mechanisms and neuroprotective strategies.
Pereira C; Agostinho P; Moreira PI; Cardoso SM; Oliveira CR
Curr Drug Targets CNS Neurol Disord; 2005 Aug; 4(4):383-403. PubMed ID: 16101556
[TBL] [Abstract][Full Text] [Related]
6. Aggregation and structure of amyloid β-protein.
Ono K; Watanabe-Nakayama T
Neurochem Int; 2021 Dec; 151():105208. PubMed ID: 34655726
[TBL] [Abstract][Full Text] [Related]
7. The murine version of BAN2401 (mAb158) selectively reduces amyloid-β protofibrils in brain and cerebrospinal fluid of tg-ArcSwe mice.
Tucker S; Möller C; Tegerstedt K; Lord A; Laudon H; Sjödahl J; Söderberg L; Spens E; Sahlin C; Waara ER; Satlin A; Gellerfors P; Osswald G; Lannfelt L
J Alzheimers Dis; 2015; 43(2):575-88. PubMed ID: 25096615
[TBL] [Abstract][Full Text] [Related]
8. Peptides as Potential Therapeutics for Alzheimer's Disease.
Ribarič S
Molecules; 2018 Jan; 23(2):. PubMed ID: 29385735
[TBL] [Abstract][Full Text] [Related]
9. Pittsburgh Compound-B (PiB) binds amyloid β-protein protofibrils.
Yamin G; Teplow DB
J Neurochem; 2017 Jan; 140(2):210-215. PubMed ID: 27943341
[TBL] [Abstract][Full Text] [Related]
10. The ongoing search for small molecules to study metal-associated amyloid-β species in Alzheimer's disease.
Savelieff MG; DeToma AS; Derrick JS; Lim MH
Acc Chem Res; 2014 Aug; 47(8):2475-82. PubMed ID: 25080056
[TBL] [Abstract][Full Text] [Related]
11. The redox chemistry of the Alzheimer's disease amyloid beta peptide.
Smith DG; Cappai R; Barnham KJ
Biochim Biophys Acta; 2007 Aug; 1768(8):1976-90. PubMed ID: 17433250
[TBL] [Abstract][Full Text] [Related]
12. A possible mechanism for the enhanced toxicity of beta-amyloid protofibrils in Alzheimer's disease.
Chen ZL; Singh PK; Calvano M; Norris EH; Strickland S
Proc Natl Acad Sci U S A; 2023 Sep; 120(36):e2309389120. PubMed ID: 37639602
[TBL] [Abstract][Full Text] [Related]
13. Novel multivalent design of a monoclonal antibody improves binding strength to soluble aggregates of amyloid beta.
Rofo F; Buijs J; Falk R; Honek K; Lannfelt L; Lilja AM; Metzendorf NG; Gustavsson T; Sehlin D; Söderberg L; Hultqvist G
Transl Neurodegener; 2021 Sep; 10(1):38. PubMed ID: 34579778
[TBL] [Abstract][Full Text] [Related]
14. Dispersible amyloid β-protein oligomers, protofibrils, and fibrils represent diffusible but not soluble aggregates: their role in neurodegeneration in amyloid precursor protein (APP) transgenic mice.
Rijal Upadhaya A; Capetillo-Zarate E; Kosterin I; Abramowski D; Kumar S; Yamaguchi H; Walter J; Fändrich M; Staufenbiel M; Thal DR
Neurobiol Aging; 2012 Nov; 33(11):2641-60. PubMed ID: 22305478
[TBL] [Abstract][Full Text] [Related]
15. Neuropathology and biochemistry of Aβ and its aggregates in Alzheimer's disease.
Thal DR; Walter J; Saido TC; Fändrich M
Acta Neuropathol; 2015 Feb; 129(2):167-82. PubMed ID: 25534025
[TBL] [Abstract][Full Text] [Related]
16. Plaque formation and the intraneuronal accumulation of β-amyloid in Alzheimer's disease.
Takahashi RH; Nagao T; Gouras GK
Pathol Int; 2017 Apr; 67(4):185-193. PubMed ID: 28261941
[TBL] [Abstract][Full Text] [Related]
17. Decoding the synaptic dysfunction of bioactive human AD brain soluble Aβ to inspire novel therapeutic avenues for Alzheimer's disease.
Li S; Jin M; Liu L; Dang Y; Ostaszewski BL; Selkoe DJ
Acta Neuropathol Commun; 2018 Nov; 6(1):121. PubMed ID: 30409172
[TBL] [Abstract][Full Text] [Related]
18. Efficient clearance of Aβ protofibrils in AβPP-transgenic mice treated with a brain-penetrating bifunctional antibody.
Syvänen S; Hultqvist G; Gustavsson T; Gumucio A; Laudon H; Söderberg L; Ingelsson M; Lannfelt L; Sehlin D
Alzheimers Res Ther; 2018 May; 10(1):49. PubMed ID: 29793530
[TBL] [Abstract][Full Text] [Related]
19. [The pathophysiology of Alzheimer's disease with special reference to "amyloid cascade hypothesis"].
Tamaoka A
Rinsho Byori; 2013 Nov; 61(11):1060-9. PubMed ID: 24450113
[TBL] [Abstract][Full Text] [Related]
20. The Essential Role of Soluble Aβ Oligomers in Alzheimer's Disease.
Wang ZX; Tan L; Liu J; Yu JT
Mol Neurobiol; 2016 Apr; 53(3):1905-1924. PubMed ID: 25833098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
